Dr Matthew Ingram, School of Pharmacy and Biomolecular Sciences,

University of BrightonUK.

Editorial

The success of the two journals “International Journal of ChemTech Research (ISSN: 0974-4290)” & “International Journal of PharmTech Research (ISSN: 0974-4304)” is of substantial importance for this area. 

These journals are open access and are a sustainable source of state of the art research knowledge.  Papers within these journals are available to all Researchers/Scientists.  There are many advantages to this approach; the essence in my opinion is the removal of barriers to knowledge and the ease of access for the readership.  It is well understood that open access allows a convenient approach to knowledge sharing. For the future I believe this open access approach has the potential to allow new knowledge to be generated, potentially through the readership sharing research ideas and making new networks.  Future publications in this journal may contain work from novel research collaborations that may have been initiated through this open access approach.  A contribution to a greater shared knowledge maybe made through these ventures.

High quality manuscripts in original and review papers from all areas associated with these journals are welcome. We are happy to discuss the suitability of any manuscript for this journal. 

Finally to the future to which we are all committed, the research conducted and published by current and future scientists will be of critical importance in achieving the goals of society.  To this end I wish you safe and prosperous endeavors with your research and look forward with great excitement to hearing of your successes.

 

Regards.

Dr Matthew Ingram.

Executive Editor.